{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:45:39Z","timestamp":1792464339448,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10239-w","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T20:04:49Z","timestamp":1732219489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Measles vaccine effectiveness in African children: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Demeke","family":"Endalamaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalkachew","family":"Nibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abaineh","family":"Munshea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feleke","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senait","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taye","family":"Zeru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesfine","family":"Tefera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizachew","family":"Yismaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"10239_CR1","unstructured":"H\u00fcbschen JM. IG-V, J Dina Measles Lancet. (1474-547X (Electronic))."},{"issue":"2296\u2013858X Print","key":"10239_CR2","first-page":"798031","volume":"8","author":"R Wang","year":"2021","unstructured":"Wang R, Jing W, Liu M, Liu J. Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and risk factors in 204 countries from 1990 to 2019. Front Med (Lausanne). 2021;8(2296\u2013858X Print):798031.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10239_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00432-018-2720-7","volume":"144","author":"Y Qi","year":"2018","unstructured":"Qi Y, Xing K, Zhang L, Zhao F, Yao M, Hu A, et al. Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model. J Cancer Res Clin Oncol. 2018;144(10):1945\u201357.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"10239_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1586\/14760584.2016.1165614","volume":"15","author":"WA Orenstein","year":"2016","unstructured":"Orenstein WA, Seib K. Beyond vertical and horizontal programs: a diagonal approach to building national immunization programs through measles elimination. Expert Rev Vaccines. 2016;15(7):791\u20133.","journal-title":"Expert Rev Vaccines"},{"key":"10239_CR5","unstructured":"Centers for Disease Control and Prevention (CDC). Measles Vaccination 2021 Available from: https:\/\/www.cdc.gov\/measles\/vaccination.html"},{"issue":"9811","key":"10239_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(10)62352-5","volume":"379","author":"WJ Moss","year":"2012","unstructured":"Moss WJ, Griffin DE. Measles Lancet. 2012;379(9811):153\u201364.","journal-title":"Measles Lancet"},{"key":"10239_CR7","unstructured":"Global vaccine action plan: monitoring, evaluation and accountability. Secretariat annual report 2020. Geneva: World Health Organization. 2020. Licence: CC BY-NC-SA 3.0 IGO.2020."},{"key":"10239_CR8","unstructured":"World Health Organization (WHO). (2019). Progress towards regional measles elimination \u2013 worldwide, 2000\u20132018. Weekly Epidemiological Record, 94(47), 557\u2013572. Available at:https:\/\/www.who.int\/publications\/i\/item\/WER9447."},{"key":"10239_CR9","unstructured":"Balcha G, Masresha RK, Eshetu M, Katsande R, Luce R, Fall A, Annick RGA, Dosseh B, Naouri CR, Byabamazima R, Perry AJ, Dabbagh P, Strebel K, Kretsinger JL, Goodson. Deo Nshimirimana. Progress toward measles Preelimination \u2014 African Region, 2011\u20132012. World Health Organization Morbidity and Mortality Weekly Report. 2014;63(13)"},{"key":"10239_CR10","unstructured":"World Health Organization. (2023). Measles and Rubella Surveillance Data. Retrieved from https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/yaws\/surveillance\/measles"},{"key":"10239_CR11","doi-asserted-by":"crossref","unstructured":"Benn CS, Aaby P, Bal\u00e9 C, Olsen J, Michaelsen KF, George E et al. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, West Africa. Lancet (London, England). 1997;350(9071):101\u20135.","DOI":"10.1016\/S0140-6736(96)12019-5"},{"key":"10239_CR12","doi-asserted-by":"crossref","unstructured":"Nkwain J, Zambou VM, Nchinjoh SC, Agbor VN, Adidja A, Mbanga C et al. Deployment of vaccine cold chain equipment in resource-limited settings: lessons from the Gavi Cold Chain Optimization Platform in Cameroon. Int Health. 2024.","DOI":"10.1093\/inthealth\/ihae010"},{"issue":"34","key":"10239_CR13","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1016\/j.vaccine.2015.04.041","volume":"33","author":"E Dube","year":"2015","unstructured":"Dube E, Gagnon D, MacDonald NE, Hesitancy SWGV. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine. 2015;33(34):4191\u2013203.","journal-title":"Vaccine"},{"issue":"5","key":"10239_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2217\/pgs.09.25","volume":"10","author":"O Poland","year":"2009","unstructured":"Poland O, Jacobson. Application of pharmacogenomics to vaccines. Pharmacogenomics. 2009;10(5):837\u201352.","journal-title":"Pharmacogenomics"},{"issue":"Suppl 1","key":"10239_CR15","first-page":"S270","volume":"187","author":"Bellini PARaWJ","year":"2003","unstructured":"Bellini PARaWJ. Update on the global distribution of genotypes ofWild type measles viruses. J Infect Dis. 2003;187(Suppl 1):S270\u20136.","journal-title":"J Infect Dis"},{"key":"10239_CR16","doi-asserted-by":"crossref","unstructured":"Alya Dabbagh RLL, Steulet C, Dumolard L, Mulders MN, Kretsinger K, Alexander JP, Rota PA, Goodson JL. Progress Toward Regional Measles Elimination \u2014 Worldwide, 2000\u201317. 2018; 67(47).","DOI":"10.15585\/mmwr.mm6747a6"},{"key":"10239_CR17","doi-asserted-by":"crossref","unstructured":"Hayley Gans LY, Rinki M, Ross DeHovitz,Bagher Forghani, Beeler J, Audet S. Yvonne Maldonado and Ann M. Arvin. Immune Responses to Measles and Mumps Vaccination of Infants at 6, 9, and 12 Months. The Journal of Infectious Diseases. 2001;184:817\u2013126.","DOI":"10.1086\/323346"},{"key":"10239_CR18","doi-asserted-by":"publisher","first-page":"c1626","DOI":"10.1136\/bmj.c1626","volume":"340","author":"E Leuridan","year":"2010","unstructured":"Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010;340:c1626.","journal-title":"BMJ"},{"issue":"16","key":"10239_CR19","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1073\/pnas.1704507114","volume":"114","author":"WA Orenstein","year":"2017","unstructured":"Orenstein WA, Ahmed R. Simply put: Vaccination saves lives. Proc Natl Acad Sci U S A. 2017;114(16):4031\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10239_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1574-6976.2012.00330.x","volume":"36","author":"DE Griffin","year":"2012","unstructured":"Griffin DE, Lin WH, Pan CH. Measles virus, immune control, and persistence. FEMS Microbiol Rev. 2012;36(3):649\u201362.","journal-title":"FEMS Microbiol Rev"},{"issue":"23","key":"10239_CR21","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1016\/j.vaccine.2013.02.070","volume":"31","author":"SL Klein","year":"2013","unstructured":"Klein SL, Poland GA. Personalized vaccinology: one size and dose might not fit both sexes. Vaccine. 2013;31(23):2599\u2013600.","journal-title":"Vaccine"},{"issue":"6","key":"10239_CR22","first-page":"1055","volume":"63","author":"WA Orenstein","year":"1985","unstructured":"Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055\u201368.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"10239_CR23","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"10239_CR24","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024. Available from: https:\/\/synthesismanual.jbi.global","DOI":"10.46658\/JBIMES-24-01"},{"key":"10239_CR25","doi-asserted-by":"crossref","unstructured":"Teklay Desta EL, Wayessa D, Wondowossen L, Kerie M. Balcha Masresha. Invalid measles vaccine dose administration and vaccine effectiveness in Ethiopia. Pan Afr Med J. 2021.","DOI":"10.11604\/pamj.2021.40.229.29028"},{"key":"10239_CR26","unstructured":"Epidemioloy of measles. cases, vaccine effectiveness, and performance towards measles elimination in the Gambia."},{"issue":"1","key":"10239_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12889-021-10436-1","volume":"21","author":"AE Jean Baptiste","year":"2021","unstructured":"Jean Baptiste AE, Wagai J, Luce R, Masresha B, Klinkenberg D, Veldhuijzen I, et al. Measles outbreak in complex emergency: estimating vaccine effectiveness and evaluation of the vaccination campaign in Borno State, Nigeria, 2019. BMC Public Health. 2021;21(1):437.","journal-title":"BMC Public Health"},{"key":"10239_CR28","doi-asserted-by":"crossref","unstructured":"Labib JR, Elsebaie EH, Abd El Fatah SAM, Shalaby SF, El Khateeb E. Assessment of Routine Measles Vaccine Effectiveness among children referring to Tertiary Fever Hospital in Egypt. Archives Pediatr Infect Dis. 2019;7(3).","DOI":"10.5812\/pedinfect.90407"},{"key":"10239_CR29","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1016\/j.vaccine.2015.04.067","volume":"33","author":"H Reena","year":"2015","unstructured":"Reena H, Calixte Shidi A, Mulumba NA, Hoff S, Gerber. Emile Okitolonda-Wemakoy, Benoit Kebela Ilunga, Jean-Jacques Muyembe, Anne W.Rimoin. Field evaluation of Measles vaccine effectiveness among children in the Democratic Republic of Congo. Vaccine. 2015;33:3407\u201314.","journal-title":"Vaccine"},{"issue":"5","key":"10239_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4269\/ajtmh.2003.68.545","volume":"68","author":"LEISEL TALLEY PS","year":"2003","unstructured":"LEISEL TALLEY PS. Short report: assessing field vaccine efficacy for measles in famine-affected rural Ethiopia. Am J Trop Med Hyg. 2003;68(5):545\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"19","key":"10239_CR31","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1016\/j.vaccine.2006.02.038","volume":"24","author":"E Mupere","year":"2006","unstructured":"Mupere E, Karamagi C, Zirembuzi G, Grabowsky M, de Swart RL, Nanyunja M, et al. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda. Vaccine. 2006;24(19):4111\u20135.","journal-title":"Vaccine"},{"key":"10239_CR32","doi-asserted-by":"crossref","unstructured":"Borus PC, Sonoiya S, Kombich J, Tukei PM, Cutts FT. Measles trends and vaccine effectiveness in Nairobi, Kenya. East Afr Med J. 2003;80(7).","DOI":"10.4314\/eamj.v80i7.8719"},{"key":"10239_CR33","doi-asserted-by":"crossref","unstructured":"Cuts FT, Mann PGSSCG, Ascherio A. A.C. Soares Field Evaluation of Measles vaccine efficacy in Mozambique American. J Epidemiol. 1990;131(2).","DOI":"10.1093\/oxfordjournals.aje.a115504"},{"key":"10239_CR34","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/infdis\/162.5.1043","volume":"162","author":"PK Peter Aaby","year":"1990","unstructured":"Peter Aaby PK, Jensen TG, Tharup J, Poulson A, Sodemann M. Maria Clotilde Da Silva, Hilton Whittle Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage. J Infect Dis. 1990;162:1043\u20138.","journal-title":"J Infect Dis"},{"key":"10239_CR35","unstructured":"Harry FH. PJW, Fred Oldfield. Measles Mortality and Vaccine Efficay in rural West Africa. Lancet. 1983."},{"key":"10239_CR36","doi-asserted-by":"crossref","unstructured":"McBean AM, Keneth SOF, Herrmann L, Gateff C. Evaluation of a mass measles immunization campain in Yaounde, Cameroun. Trans R Soc Trop Med Hyg. 1976;70(3).","DOI":"10.1016\/0035-9203(76)90040-7"},{"issue":"suppl1","key":"10239_CR37","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1093\/infdis\/jir110","volume":"204","author":"DE Sugerman","year":"2011","unstructured":"Sugerman DE, Fall A, Guigui M-T, N\u2019Dolie M, Balogun T, Wurie A, et al. Preplanned National Measles Vaccination Campaign at the beginning of a Measles Outbreak\u2014Sierra Leone, 2009\u20132010. J Infect Dis. 2011;204(suppl1):S260\u20139.","journal-title":"J Infect Dis"},{"issue":"13","key":"10239_CR38","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1016\/j.vaccine.2020.02.029","volume":"38","author":"RM Coulborn","year":"2020","unstructured":"Coulborn RM, Nackers F, Bachy C, Porten K, Vochten H, Ndele E, et al. Field challenges to measles elimination in the Democratic Republic of the Congo. Vaccine. 2020;38(13):2800\u20137.","journal-title":"Vaccine"},{"issue":"1","key":"10239_CR39","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1186\/s12889-022-14069-w","volume":"22","author":"M Yousif","year":"2022","unstructured":"Yousif M, Hong H, Malfeld S, Smit S, Makhathini L, Motsamai T, et al. Measles incidence in South Africa: a six-year review, 2015\u20132020. BMC Public Health. 2022;22(1):1647.","journal-title":"BMC Public Health"},{"issue":"5","key":"10239_CR40","first-page":"427","volume":"75","author":"JC Luthi","year":"1997","unstructured":"Luthi JC, Kessler W, Boelaert M. [A survey on vaccine efficacy in the city of Bongor (Chad) and its operational consequences for the vaccination program]. Bull World Health Organ. 1997;75(5):427\u201333.","journal-title":"Bull World Health Organ"},{"key":"10239_CR41","doi-asserted-by":"crossref","unstructured":"Alexis Pillsbury HQ. An assessment of measles vaccine effectiveness, Australia, 2006\u201312. 2015;6(3).","DOI":"10.5365\/wpsar.2015.6.2.007"},{"key":"10239_CR42","unstructured":"Syed MA, Cutts FTC, Hossain MJ, Wahedi OK, Nahar N, Islam D, Shaha NC, Mahalanabis D. Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh."},{"issue":"2","key":"10239_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21101\/cejph.a4754","volume":"26","author":"BT Sanjin Musa","year":"2018","unstructured":"Sanjin Musa BT, Sutka, \u0106ati\u0107, Zijada Smajlagi\u0107. Assessment of vaccine effectiveness during measles outbreak in the federation of Bosnia and Herzegovina, 2014\u20132015. Cent Eur J Public Health. 2018;26(2):79\u201382.","journal-title":"Cent Eur J Public Health"},{"key":"10239_CR44","doi-asserted-by":"crossref","unstructured":"Karen A, Hennessey Nl -N, Craciun M-D, Toma F, Wattigney W, Peter M. Strebel. Measles Epidemic in Romania, 1996\u20131998: Assessment of Vaccine Effectiveness by Case-Control and Cohort studies. Am J Epidemiol. 1999;150(11).","DOI":"10.1093\/oxfordjournals.aje.a009952"},{"issue":"52","key":"10239_CR45","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1016\/j.vaccine.2012.10.036","volume":"30","author":"JC Shearer","year":"2012","unstructured":"Shearer JC, Walker DG, Risko N, Levine OS. The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis. Vaccine. 2012;30(52):7582\u20137.","journal-title":"Vaccine"},{"key":"10239_CR46","unstructured":"World Health Organization. (2021). Measles. Retrieved from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/measles)"},{"issue":"1","key":"10239_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3201\/eid1301.060649","volume":"13","author":"C Cohen","year":"2007","unstructured":"Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004\u20132005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12\u20137.","journal-title":"Emerg Infect Dis"},{"key":"10239_CR48","unstructured":"Aysha Zahidie SW, Zafar Fatmi. Vaccine effectiveness and risk factors associated with measles among children presenting to the hospitals of Karachi, Pakistan."},{"issue":"17","key":"10239_CR49","doi-asserted-by":"publisher","first-page":"1800529","DOI":"10.2807\/1560-7917.ES.2019.24.17.1800529","volume":"24","author":"J Bitzegeio","year":"2019","unstructured":"Bitzegeio J, Majowicz S, Matysiak-Klose D, Sagebiel D, Werber D. Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014\/15: evidence for waning immunity. Eurosurveillance. 2019;24(17):1800529.","journal-title":"Eurosurveillance"},{"issue":"12 Suppl 2","key":"10239_CR50","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.1093\/infdis\/jiaa793","volume":"224","author":"PA Gastanaduy","year":"2021","unstructured":"Gastanaduy PA, Goodson JL, Panagiotakopoulos L, Rota PA, Orenstein WA, Patel M. Measles in the 21st Century: Progress toward Achieving and sustaining elimination. J Infect Dis. 2021;224(12 Suppl 2):S420\u20138.","journal-title":"J Infect Dis"},{"issue":"12","key":"10239_CR51","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1080\/21645515.2021.2013078","volume":"17","author":"R Sato","year":"2021","unstructured":"Sato R, Haraguchi M. Effect of measles prevalence and vaccination coverage on other disease burden: evidence of measles immune amnesia in 46 African countries. Hum Vaccines Immunotherapeutics. 2021;17(12):5361\u20136.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10239_CR52","doi-asserted-by":"crossref","unstructured":"JulianPTHiggins SGT, Jonathan J, Deeks, Douglas G, Altman. Measuring inconsistency in meta-analyses. BMJ. 2003;327.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"10239_CR53","unstructured":"Uzicanin A, Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. (1537\u20136613 (Electronic))."},{"key":"10239_CR54","doi-asserted-by":"crossref","unstructured":"Patel Mk Fau -, Goodson JL, Goodson Jl Fau -, Alexander JP Jr., Jp A Jr Fau -, Kretsinger K, Kretsinger K. Fau - Sodha SV, Sodha Sv Fau - Steulet C, Steulet C Fau - Gacic-Dobo M. Progress Toward Regional Measles Elimination - Worldwide, 2000\u20132019. (1545-861X (Electronic)).","DOI":"10.15585\/mmwr.mm6848a1"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10239-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10239-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10239-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T21:23:46Z","timestamp":1732224226000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10239-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10239"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10239-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1330"}}